Complete Filing Data
Medicale Corp. reported Stockholders Equity of -$40.7 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Medicale Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$41.2K | -$58.2K | -$37.1K | -$46.4K | -$32.2K | -$1.9K |
| Operating Income Loss | -$33.5K | -$54.7K | -$37.6K | -$44.0K | -$32.2K | -$1.9K |
| General And Administrative Expense | $33.5K | $54.7K | $37.6K | $44.0K | $32.2K | $1.9K |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$58.2K | -$37.6K | -$44.0K | -$32.2K | -$1.9K | |
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | $455.00 | -$2.4K | |||
| Operating Expenses | $33.5K | $54.7K | $37.6K | $44.0K | $32.2K | $1.9K |
| Interest Expense Other | $7.5K | $3.5K | ||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | ||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | ||||||
| Income Loss From Continuing Operations Per Diluted Share | ||||||
| Income Loss From Continuing Operations Per Basic Share | ||||||
| Revenues | $0.00 | $0.00 | $0.00 | |||
| Income Loss From Continuing Operations | -$58.2K | -$37.6K | -$44.0K | |||
| Amortization Of Intangible Assets | $2.4K | $2.4K | $0.00 | |||
| Other Nonoperating Expense | $159.00 | $0.00 | ||||
| Income Loss From Discontinued Operations Net Of Tax1 | $0.00 | $455.00 | -$2.4K | |||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | ||||||
| Income Loss From Continuing Operations1 | -$58.2K | -$37.6K | -$44.0K | |||
| Net Income Loss For Period Operating | ||||||
| Net Income Loss For Period From Discontinued Operations |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$5.3K | -$5.5K | -$8.3K | -$16.7K | -$10.5K | -$11.6K | -$19.3K | -$8.5K | -$6.1K | -$8.3K | -$6.7K | -$6.6K | -$18.7K | -$6.9K | -$7.2K | -$11.5K |
| Operating Income Loss | -$3.1K | -$3.6K | -$6.3K | -$15.0K | -$9.3K | -$10.6K | -$19.3K | -$8.5K | -$6.1K | -$8.7K | -$6.7K | -$6.0K | -$18.1K | -$6.9K | -$7.2K | -$11.5K |
| General And Administrative Expense | $3.1K | $3.6K | $6.3K | $15.0K | $9.3K | $10.6K | $19.3K | $8.5K | $6.1K | $8.7K | $6.7K | $6.0K | $18.1K | $6.9K | $7.2K | $11.5K |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.5K | -$11.6K | -$19.3K | -$8.5K | -$6.1K | -$8.7K | -$6.0K | -$18.1K | -$11.5K | |||||||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $455.00 | -$600.00 | -$600.00 | ||||||||
| Operating Expenses | $3.1K | $3.6K | $6.3K | $15.0K | $9.3K | $10.6K | $19.3K | |||||||||
| Interest Expense Other | $2.1K | $2.0K | $1.8K | $1.7K | $1.2K | $961.00 | $0.00 | $0.00 | $0.00 | |||||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Income Loss From Continuing Operations Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Revenues | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Income Loss From Continuing Operations | -$10.5K | $0.00 | -$19.3K | -$8.5K | $0.00 | -$8.7K | ||||||||||
| Amortization Of Intangible Assets | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | $600.00 | ||||||||||
| Other Nonoperating Expense | $0.00 | $159.00 | $0.00 | $0.00 | ||||||||||||
| Income Loss From Discontinued Operations Net Of Tax1 | $0.00 | $455.00 | ||||||||||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$6.1K | -$8.7K | -$6.0K | -$18.1K | ||||||||||||
| Income Loss From Continuing Operations1 | -$19.3K | -$8.7K | ||||||||||||||
| Net Income Loss For Period Operating | $8.7K | $18.1K | ||||||||||||||
| Net Income Loss For Period From Discontinued Operations | -$455.00 | $600.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$40.7K | -$54.8K | -$8.4K | -$1.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $159.00 | $0.00 | $18.5K | |||
| Retained Earnings Accumulated Deficit | -$175.8K | -$117.6K | -$80.5K | -$34.1K | -$1.9K | |
| Liabilities Current | $15.5K | $40.9K | $54.8K | $36.6K | $13.6K | |
| Liabilities And Stockholders Equity | $159.00 | $159.00 | $0.00 | $28.3K | $12.2K | |
| Assets Current | $159.00 | $159.00 | $0.00 | $18.7K | $200.00 | |
| Assets | $159.00 | $159.00 | $0.00 | $28.3K | $12.2K | |
| Common Stock Value | $592.00 | $592.00 | $592.00 | $592.00 | $340.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$159.00 | $0.00 | $159.00 | -$18.5K | $18.5K | $0.00 |
| Cash | $18.5K | $0.00 | ||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | $12.0K | $12.0K | $12.0K | |||
| Debt Forgiveness By Related Party | $0.00 | $51.2K | $51.2K | |||
| Accounts Payable And Other Accrued Liabilities Current | $3.5K | $8.4K | $25.0K | $25.0K | ||
| Liabilities Noncurrent | $83.6K | $0.00 | ||||
| Liabilities | $99.1K | $40.9K | ||||
| Convertible Long Term Notes Payable | $83.6K | $0.00 | ||||
| Accounts Payable And Accrued Liabilities Current | $0.00 | $13.0K | ||||
| Interest Payable Current | $3.5K | |||||
| Finite Lived Intangible Assets Net | $12.0K | |||||
| Cash Provided By Used In Operating Activities Discontinued Operations | $0.00 | $9.6K | ||||
| Cash And Cash Equivalents At Carrying Value | $18.5K | $0.00 | ||||
| Intangible Assets Net Excluding Goodwill | $0.00 | $9.6K | ||||
| Accrued Liabilities Current | ||||||
| Accounts Payable Current | ||||||
| Restricted Cash |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$145.4K | -$140.1K | -$129.4K | -$123.9K | -$115.6K | -$98.9K | -$82.1K | -$71.6K | -$60.0K | -$26.5K | -$18.0K | -$11.8K | -$40.4K | -$33.7K | -$27.1K | -$1.8K | $5.1K | -$12.9K | -$1.4K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $0.00 | $344.00 | $3.4K | $20.8K | $23.9K | $0.00 | |||
| Retained Earnings Accumulated Deficit | -$222.3K | -$217.0K | -$206.3K | -$200.8K | -$188.5K | -$159.0K | -$148.5K | -$136.9K | -$94.9K | -$88.8K | -$66.1K | -$59.4K | -$52.8K | -$20.6K | -$13.4K | -$1.9K | |||||
| Liabilities Current | $32.2K | $33.7K | $29.4K | $25.9K | $18.2K | $14.1K | $13.0K | $12.0K | $18.1K | $12.0K | $48.2K | $42.6K | $39.6K | $29.8K | $24.5K | $13.6K | |||||
| Liabilities And Stockholders Equity | $0.00 | $0.00 | $0.00 | $0.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $7.8K | $8.9K | $12.6K | $34.9K | $11.6K | $12.2K | |||||
| Assets Current | $0.00 | $0.00 | $0.00 | $0.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $0.00 | $544.00 | $3.6K | $24.1K | $200.00 | $200.00 | |||||
| Assets | $0.00 | $0.00 | $0.00 | $0.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $159.00 | $7.8K | $8.9K | $12.6K | $34.9K | $11.6K | $12.2K | |||||
| Common Stock Value | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | $592.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $0.00 | $0.00 | $0.00 | $159.00 | -$15.1K | $0.00 | |||||||||||||||
| Cash | $23.9K | $0.00 | |||||||||||||||||||
| Liabilities Of Disposal Group Including Discontinued Operation Current | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | |||||||||||
| Debt Forgiveness By Related Party | $0.00 | $51.2K | $51.2K | $0.00 | |||||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | $2.1K | $962.00 | $0.00 | $6.1K | $0.00 | $34.0K | $31.0K | ||||||||||||||
| Liabilities Noncurrent | $113.2K | $106.4K | $100.0K | $98.0K | $93.6K | $68.1K | $58.8K | $48.2K | |||||||||||||
| Liabilities | $145.4K | $140.1K | $129.4K | $123.9K | $111.8K | $82.2K | $71.8K | $60.2K | |||||||||||||
| Convertible Long Term Notes Payable | $113.2K | $106.4K | $100.0K | $98.0K | $93.6K | $68.1K | $58.8K | $48.2K | |||||||||||||
| Accounts Payable And Accrued Liabilities Current | $7.0K | $10.6K | $8.4K | $6.9K | $28.0K | $25.0K | |||||||||||||||
| Interest Payable Current | $13.2K | $11.0K | $9.0K | $7.0K | |||||||||||||||||
| Finite Lived Intangible Assets Net | $9.0K | $9.6K | $10.8K | $11.4K | $12.0K | ||||||||||||||||
| Cash Provided By Used In Operating Activities Discontinued Operations | $0.00 | $600.00 | |||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $23.9K | $0.00 | |||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $7.8K | $8.4K | |||||||||||||||||||
| Accrued Liabilities Current | $5.2K | $3.5K | $10.8K | $8.5K | $603.00 | $603.00 | |||||||||||||||
| Accounts Payable Current | $995.00 | $0.00 | $12.0K | $12.0K | $12.0K | $12.0K | |||||||||||||||
| Restricted Cash | $0.00 | $344.00 | $18.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | $22.8K | $83.6K | $25.9K | $6.1K | $36.2K | $1.1K |
| Net Cash Provided By Used In Operating Activities | -$23.0K | -$83.6K | -$25.7K | -$24.6K | -$17.8K | -$1.1K |
| Proceeds From Related Party Debt | $0.00 | $25.9K | $6.1K | $11.0K | $602.00 | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$4.9K | $11.4K | $12.0K | $12.0K | $13.0K | |
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Proceeds From Convertible Debt | $22.8K | $83.6K | $0.00 | |||
| Increase Decrease In Accrued Liabilities | $7.5K | $0.00 | ||||
| Increase Decrease In Accounts Payable | $10.6K | -$4.9K | ||||
| Proceeds From Issuance Of Common Stock | $0.00 | $25.2K | $520.00 | |||
| Increase Decrease In Due To Related Parties | -$20.5K | $0.00 | $200.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 | Q4 2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | $6.7K | $10.0K | $27.7K | $5.4K | $0.00 | $7.9K |
| Net Cash Provided By Used In Operating Activities | -$6.7K | -$10.0K | -$27.7K | $159.00 | -$15.1K | -$7.9K |
| Proceeds From Related Party Debt | $5.4K | $0.00 | $7.9K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$8.4K | $3.0K | $3.0K | $3.0K | ||
| Net Cash Provided By Used In Investing Activities | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Proceeds From Convertible Debt | $6.7K | $10.0K | $27.7K | $0.00 | ||
| Increase Decrease In Accrued Liabilities | $2.1K | $1.7K | $0.00 | |||
| Increase Decrease In Accounts Payable | -$3.6K | $5.0K | -$8.4K | |||
| Proceeds From Issuance Of Common Stock | $0.00 | |||||
| Increase Decrease In Due To Related Parties | -$20.5K | $5.4K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 3.6M | |
| Weighted Average Number Of Shares Outstanding Basic | 5.9M | 5.9M | 5.9M | 5.9M | 3.6M | |
| Common Stock Shares Authorized | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 3.4M | |
| Common Stock Shares Issued | 5.9M | 5.9M | 5.9M | 5.9M | 3.4M | |
| Earnings Per Share Basic | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 3.6M | 3.3M | ||||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | ||||||
| Net Loss Per Share Basic And Diluted |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | |||
| Weighted Average Number Of Shares Outstanding Basic | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | |||
| Common Stock Shares Authorized | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | 75.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 3.4M | ||
| Common Stock Shares Issued | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 5.9M | 3.4M | ||
| Earnings Per Share Basic | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 5.9M | 3.4M | |||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | 5.9M | 4.3M | |||||||||||||||
| Net Loss Per Share Basic And Diluted | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Additional Paid In Capital | $76.3K | $76.3K | $25.1K | $25.1K | $180.00 | |
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Expenses | $7.7K | $3.5K | $0.00 | |||
| Due To Related Parties Current | $11.6K | $603.00 | ||||
| Due From Related Parties Current | $0.00 | $200.00 | $200.00 | |||
| Related Party Advances | $0.00 | $20.5K | $17.8K | |||
| Adjustments To Additional Paid In Capital Other | $51.2K | |||||
| Due To Related Parties Current1 | ||||||
| Stock Issued During Period Value New Issues | $25.2K | $200.00 | ||||
| Short Term Borrowings |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $76.3K | $25.1K | $25.1K | $25.1K | $25.1K | $180.00 | $180.00 | ||||
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Other Expenses | $2.1K | $2.0K | $2.0K | $1.7K | $1.2K | $961.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Due To Related Parties Current | $0.00 | $17.8K | $14.2K | $11.6K | $11.6K | |||||||||||||||
| Due From Related Parties Current | $0.00 | $200.00 | $200.00 | |||||||||||||||||
| Related Party Advances | $0.00 | |||||||||||||||||||
| Adjustments To Additional Paid In Capital Other | $51.2K | |||||||||||||||||||
| Due To Related Parties Current1 | $0.00 | $0.00 | $20.5K | $0.00 | $17.8K | |||||||||||||||
| Stock Issued During Period Value New Issues | $25.2K | |||||||||||||||||||
| Short Term Borrowings | $7.0K | $4.0K | $1.0K | $1.0K |
Most recent annual filing with the SEC: January 12, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.